BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37685667)

  • 21. Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia.
    Kesselmeier M; Pletz MW; Blankenstein AL; Scherag A; Bauer T; Ewig S; Kolditz M
    Clin Microbiol Infect; 2021 Sep; 27(9):1345.e1-1345.e6. PubMed ID: 33049414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis.
    Briel M; Spoorenberg SMC; Snijders D; Torres A; Fernandez-Serrano S; Meduri GU; Gabarrús A; Blum CA; Confalonieri M; Kasenda B; Siemieniuk RAC; Boersma W; Bos WJW; Christ-Crain M; ; ;
    Clin Infect Dis; 2018 Jan; 66(3):346-354. PubMed ID: 29020323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospitalization costs of adult community-acquired pneumonia in England.
    Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
    J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of rehospitalization among elderly patients admitted to a rehabilitation hospital: the role of polypharmacy, functional status, and length of stay.
    Morandi A; Bellelli G; Vasilevskis EE; Turco R; Guerini F; Torpilliesi T; Speciale S; Emiliani V; Gentile S; Schnelle J; Trabucchi M
    J Am Med Dir Assoc; 2013 Oct; 14(10):761-7. PubMed ID: 23664484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in hospitalizations for community-acquired pneumonia in Spain: 2004 to 2013.
    de Miguel-Díez J; Jiménez-García R; Hernández-Barrera V; Jiménez-Trujillo I; de Miguel-Yanes JM; Méndez-Bailón M; López-de-Andrés A
    Eur J Intern Med; 2017 May; 40():64-71. PubMed ID: 27979670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study.
    Holter JC; Ueland T; Jenum PA; Müller F; Brunborg C; Frøland SS; Aukrust P; Husebye E; Heggelund L
    PLoS One; 2016; 11(2):e0148741. PubMed ID: 26849359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the use of blood cultures in the management of children hospitalized for community-acquired pneumonia.
    McCulloh RJ; Koster MP; Yin DE; Milner TL; Ralston SL; Hill VL; Alverson BK; Biondi EA
    PLoS One; 2015; 10(2):e0117462. PubMed ID: 25658645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.
    Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J;
    Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients.
    Martins M; Boavida JM; Raposo JF; Froes F; Nunes B; Ribeiro RT; Macedo MP; Penha-Gonçalves C
    BMJ Open Diabetes Res Care; 2016; 4(1):e000181. PubMed ID: 27252873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Mortality and Use of RISC Scoring System in Hospitalized Under-Five Children Due to WHO Defined Severe Community Acquired Pneumonia.
    Kapoor A; Awasthi S; Kumar Yadav K
    J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35727140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonia in hospitalized elderly hip fracture patients: the effects on length of hospital-stay, in-hospital and thirty-day mortality and a search for potential predictors.
    Salarbaks AM; Lindeboom R; Nijmeijer W
    Injury; 2020 Aug; 51(8):1846-1850. PubMed ID: 32482422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality.
    Oster G; Berger A; Edelsberg J; Weber DJ
    J Med Econ; 2013; 16(6):809-19. PubMed ID: 23574431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-hospital mortality for aspiration pneumonia in a tertiary teaching hospital: A retrospective cohort review from 2008 to 2018.
    Shin D; Lebovic G; Lin RJ
    J Otolaryngol Head Neck Surg; 2023 Mar; 52(1):23. PubMed ID: 36879258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of systemic steroids on patients with community-acquired pneumonia: Observational study from a tertiary care hospital of a developing country.
    Iqbal N; Irfan M; Siddiqui F; Arshad V; Zuabairi ABS
    Respir Investig; 2020 Nov; 58(6):495-501. PubMed ID: 32665194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of in-hospital mortality and length of stay in community-acquired pneumonia: a 5-year multi-centre case control study of adults in a developing country.
    Iroezindu MO; Isiguzo GC; Chima EI; Mbata GC; Onyedibe KI; Onyedum CC; John-Maduagwu OJ; Okoli LE; Young EE
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):445-55. PubMed ID: 27618923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
    Hsu JL; Siroka AM; Smith MW; Holodniy M; Meduri GU
    Int J Infect Dis; 2011 Jun; 15(6):e382-7. PubMed ID: 21393043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors associated with prolonged hospital stay in community-acquired pneumonia].
    Garcia-Vidal C; Carratalà J; Díaz V; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):160-4. PubMed ID: 19306716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to antibiotic administration and patient outcomes in community-acquired pneumonia: results from a prospective cohort study.
    Fally M; Israelsen S; Benfield T; Tarp B; Ravn P
    Clin Microbiol Infect; 2021 Mar; 27(3):406-412. PubMed ID: 32896655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Reactive Protein as a Predictor of Survival and Length of Hospital Stay in Community-Acquired Pneumonia.
    Travlos A; Bakakos A; Vlachos KF; Rovina N; Koulouris N; Bakakos P
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
    Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
    Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.